Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
SA MP LE VO L U M E 1 0 NUMBER 7 Skin Discolorations and Their Treatment Loyd V. Allen, Jr., Ph.D. Introduction Having clear, smooth, evenly colored skin is desired by many; some are fortunate to have it, but most are not. Skin color can be altered by disease or exposure to miscellaneous agents; some patients have a change in pigment coloration as a result of some inflammatory disease, including acne or atopic dermatitis. The skin cells contain melanocytes that produce melanosomes, which are pigment granules containing the complex protein or brown skin-coloring pigment, melanin. The pituitary hormone produces melanocyte stimulating hormone, or MSH, which stimulates melanin production. There are approximately 800 to 1000 melanocytes per square millimeter of human epidermis; being the same in both light and dark skin individuals but the rate of production of the pigment varies. A number of conditions cause the melanocytes to become either abnormal or abnormally distributed in the skin. Most skin conditions that cause discoloration are actually harmless; causing more cosmetic and emotional discomfort than medical problems.1,2 Skin hyperpigmentation and photoaging are considered by many to be cosmetically unacceptable and they search for treatment methods to minimize it. Background Exposure to such pigments as carotene can result in carotenemia, iron can cause hemodiserin and silver can cause argyria. Other pigmentation problems can be caused by gold used in rheumatoid arthritis treatments, tattooing, homogentisic acid in ochronosis and bile pigments. Changes in skin color may be from hyperpigmentation or hypopigmentation; both can be primary or secondary to other disorders in the body. Table 1 lists common causes of pigmentation disorders. Primary hyperpigmentation disorders include those that are nevoid, congenital or acquired. Disorders include pigmented nevi, ephelides (juvenile freckles—an inherited characteristic—age spots and café-au-lait spots), and lentigines (solar lentigines, senile lentigines, senile freckles, liver-spots). Other hyperpigmentation disorders include arsenical melanosis and those associated with Addison’s disease. Neurofibromatosis may produce axillary freckling and caféau-lait spots. A patterned facial hyperpigmentation of the face, usually as a result of estrogen therapy, is melasma, or chloasma; occurring in about 30 to 50% of women taking oral contraceptives.1 Primary hypopigmentation and depigmentation disorders include vitiligo, albinism and piebaldism. Pigment cells, or melanocytes, are destroyed in vitiligo, which occurs in aobut 1% of the population and may be associated with hyperthyroidism, hypothyroidism, pernicious anemia, diabetes mellitus and Addison’s disease. Albinism is a collection of genetically determined traits. Piebaldism is a localized hypomelanosis producing a white forelock. Tuberous sclerosis may produce hypopigmented ash leaf spots and hypopigmented halos can often be seen around nevi and may occur around melanomas.1 Secondary hyperpigmentation disorders include those occurring following a separate dermatologic condition, including acne; it is most commonly seen in dark-skinned individuals and is called postinflammatory hyperpigmentation. Another disorder is called Berloque hyperpigmentation, which is due to phototoxicity from chemicals in the rinds of limes and other citrus fruits, and to celery. Pigmentation disorders can also be caused by some drugs, including chloroquine, chlorpromazine, minocycline, and amiodarone. Benzoyl peroxide, fluorouracil and tretinoin can cause hyperpigmentation as well as fixed drug eruptions resulting from phenolphthalein in laxatives, trimethoprim-sulfamethoxazole, NSAIDs and tetracyclines.1 Secondary hypopigmentation, or leukoderma may result as a complication due to atopic dermatitis, Table 1: Causes of Generalized Hyperpigmentation. Congenital • Familial • Racial Ultraviolet light irradiation Endocrine disorders • Acromegaly • Chronic primary hypoadrenalism • Cushing’s syndrome with high ACTH • Estrogens • Pregnancy Systemic Disease • Biliary cirrhosis, primary • Chronic renal failure • Cachexia (Tuberculosis, Malignancy) • Hemochromatosis • Malabsorption (Whipples disease, Celiac disease) Drug Induced (See table 2) lichen planus, psoriasis, discoid lupus erythrematosus and lichen simplex chronicus. Liquid nitrogen used on patients with olive or darker complexions may result in hypopigmentation or depigmentation. High concentrations of corticosteroid injected intralesionally or intra-articularly may also cause localized temporary hypopigmentation.1 Some body chemicals, such as bilirubin, can be deposited in the skin and cause a discoloration. Heavy metals, such as silver, gold and iron each have a characteristic color when they can be seen within the skin. Table 2 lists a number of these agents as well as some drugs that can cause pigmentation disorders. Symptoms Table 2: Agents or Drugs that can Cause Skin Hyperpigmentation. Amiodarone Arsenic Benzoyl peroxide Bleomycin Busulfan Chloroquine Chlorpromazine Cyclophosphamide Estrogens Fluorouracil Heavy metal poisoning Hydroxychloroquine Iron Minocycline Nicotinic acid (Niacin) Nonsteroidal anti-inflammatory agents (NSAIDs) Phenolphthalein Phenothiazines Phenytoin Steroids Tetracycline Tretinoin Trimethoprim-Sulfamethoxazole SA MP LE Questions for the medical history of the patient can involve family (Does anyone else in your family have a similar problem?), timing (When did the discoloration begin? Was it sudden? Is it getting worse, and if so, how quickly), quality (Describe the change. Is the skin getting darker or lighter?), location (Where is the discoloration? Is there a pattern to it?), aggravating factors (What medications are you using? Are you often exposed to the sun or a sun lamp? What is your diet?) and miscellaneous questions involving other symptoms they might have as well as any rashes or skin lesions. A trained dermatologist can generally recognize the pattern of discoloration immediately and name and characterize the discoloration. Some of these pigment changes reflect internal diseases that must be identified and treated. Table 3 lists some symptoms, diseases and causative factors related to hyperpigmentation disorders. Table 3: Symptoms of and Disorders Related to Hyperpigmentation. Acanthosis nigricans Actinic keratosis-sometimes causing a red-brown skin Biliary cirrhosis Birthmarks (Nevus) Bruise Blue skin Café-au-lait spots Chloasma Dry gangrene Erythema abigne—a red brown discoloration resulting from heat exposure Familial polyposis; results in a darkening of the gums Freckles Frostbite Hemochromatosis (Bronze diabetes) Jaundice Kaposi’s sarcoma-purple spots Malignant melanoma McCune-Albright Syndrome-increased pigmentation, “café au lait” spots Moles Mongolian blue spot Necrotizing fasciitis-violet skin Neurofibromatosis, or von Recklinghausen’s diseases Peutz-Jeghers syndrome (peri-oral pigmentation) Polycystic ovary syndrome-thickened darkened skin patches Porphyria cutanea tarda Port wine stains Pregnancy: “Mask of pregnancy”, darkening of the cheeks and forehead; also, darkening of the nipples, genitals and a line down the central abdomen, linea nigra. Purple skin Sarcoidosis-purple skin patches Scleroderma Seborrheic wart Senile wart Sun sensitivity Uremia-sallow complexion Varicose veins Venous ulceration from long-term varicose veins Visceral leishmaniasis Table 5: Example antioxidants and adjuvants used in hydroquinone preparations.* Agent Oil Soluble Ascorbyl palmitate Butylated hydroxyanisole Butylated hydroxytoluene Lecithin -Lipoic acid Tocopherols ( , Δ, ) Water Soluble Ascorbic acid Potassium metabisulfite Sodium bisulfite Sodium metabisulfite Sodium sulfite Adjuvants Ascorbic acid Citric acid EDTA and salts Tartaric acid *See IJPC 3(1); 1999: 52-55. Concentration Range 0.01-0.5% 0.005-0.02% 0.005-0.02% 0.05-0.5% 0.01-0.5% 0.05-1% 0.05-1% 0.01-1% 0.01-0.2% 0.02-0.1% 0.005-0.01% 0.02-0.1% 0.01-0.02% Treatment This article will only address hyperpigmentation treatment. The goal of therapy in hyperpigmentation disorders is to lighten the skin so it blends into the normal skin in the area. Most products (See Table 4) used to lighten the skin contain hydroquinone. Other drugs commonly used in the treatment of hyperpigmentation disorders include azelaic acid, glycolic acid, hydrocortisone, kojic acid, tretinoin and triamcinolone. These are listed in Table 4 and antioxidants and adjuvants used in their formulations are listed in Table 5. Normally, these agents are somewhat irritating to sensitive skin. Treatments may take three to six months to produce improvement. Laser treatments are also available. For treatment of freckles, age spots and other discolorations, using a sunscreen with a sun protection factor (SPF) of at least 15 is a must. References 1. Berger TG. Skin, Hair, & Nails. In: Tierney LM Jr, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis & Treatment. New York: Lange Medical Books/McGrawHill; 2003: 138-140. 2. Esterly JS, West LE, West DP. Skin Hyperpigmentation and Photoaging. In: Berardi RR, ed. Handbook of Nonprescription Drugs. 14th ed. Washington, DC: American Pharmaceutical Association; 2004: 955-967. Table 4: Active ingredients used in the treatment of skin hyperpigmentation. Ingredient Azelaic acid Glycolic acid Hydroquinone Hydrocortisone Kojic acid Tretinoin Triamcinolone % Used 5-20 1-20 1-15 0.5-1 2-10 0.025-0.05 0.025-0.5 Example Formulations Rx Hydroquinone 5% in Isopropyl Alcohol Rx Hydroquinone 5% Topical Gel Rx Hydroquinone 5% Topical StickWater Repellant Rx Hydroquinone 5% Topical StickWater Soluble Rx Dexamethasone 0.1%, Hydroquinone 5% and Retinoic Acid 0.1% Ointment Rx Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Gel Rx Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Cream Rx Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Ointment Rx Hydrocortisone 1%, Hydroquinone 5% and Glycolic Acid 5% Lotion Rx Hydroquinone 5% Cream RxTriad-A publication of the International Journal of Pharmaceutical Compounding. © 2007 IJPC. All rights reserved.